Veeva Systems Inc.

VEEV Healthcare Health Information Services

Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.

310.30 2.73 −0.87%
Market cap
$50.7B
P/E
50.0×
Fwd P/E
26.9×
Dividend yield
—
F-score
7/9
Altman Z
13.57
Beneish M
−2.63
Dividend safety
n/a

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Jan '17 Jan '18 Jan '19 Jan '20 Jan '21 Jan '22 Jan '23 Jan '24 Jan '25 Jan '26
Net Income
77.57 151.18 229.83 301.12 380.00 427.39 487.71 525.71 714.14 908.91
Depreciation & Amortization
29.86 32.31 30.02 37.11 53.27 59.76 47.59 24.29 30.47 44.70
Non Cash Items (Other)
39.81 55.28 68.36 117.33 193.63 256.65 237.83 300.52 337.83 553.56
Accounts Receivable Change
(39.67) (52.13) (83.77) (70.09) (188.45) (83.08) (91.08) (104.00) (168.97) (254.55)
Accounts Payable Change
1.11 1.40 1.82 2.81 0.75 (3.00) 21.43 (10.23) (1.96) 6.08
Change in payables and accrued liability
0.34 7.15 0.96 (15.23) 13.89 9.44 9.28 (4.25) (1.41) 2.98
Income tax paid
0.91 (2.52) 0.64 1.13 (3.02) 5.28 (2.81) 6.92 (2.84) (2.33)
Change in other assets and liabilities
34.08 40.77 62.97 63.19 101.19 92.02 70.54 172.39 182.80 155.88
Operating Cash Flow
144.01 233.44 310.83 437.38 551.25 764.46 780.47 911.34 1,090.05 1,415.23
Capital expenditures
(7.51) (11.37) (9.82) (4.32) (8.68) (14.21) (13.51) (26.20) (20.52) (29.13)
Net Aquisitions
— — — (448.16) — (7.78) — — — —
Short Term Investments Change (Net)
(89.25) (143.15) (94.05) (64.43) (324.95) (324.16) (994.17) (1,050.15) (679.62) (1,075.23)
Investing cash flow
(96.75) (154.52) (103.87) (516.91) (333.63) (346.15) (1,007.68) (1,076.35) (700.14) (1,104.36)
Repayment/Issuance of Debt (Net)
— — — (0.98) (1.04) (0.38) — — — —
Equity Repurchase (Common, Net)
12.36 20.77 25.91 10.99 34.86 51.54 43.65 62.69 105.54 83.91
Other financial activities
25.61 55.46 74.02 133.28 208.14 (55.29) (63.03) (78.87) (79.42) (93.25)
Financing cash flow
37.98 20.77 25.91 10.01 33.82 (4.14) (19.38) (16.19) 26.12 (9.33)
Exchange Rate Adjustment
0.09 3.09 (2.08) (2.86) 0.48 (4.66) (4.99) (1.78) (1.73) 0.92
Change in Cash
85.32 102.78 230.79 (72.38) 251.91 409.51 (251.57) (182.98) 414.29 302.45
Beginning Cash
133.28 218.61 321.39 552.18 479.80 731.71 1,141.23 889.65 706.67 1,120.96
Ending Cash
218.61 321.39 552.18 479.80 731.71 1,141.23 889.65 706.67 1,120.96 1,423.41
Stock Based Compensation
40.80 54.05 76.43 115.91 185.00 234.64 351.91 393.73 437.35 472.70
Dividends Paid (Common)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash/Marketcap
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(3.23) (5.33) (17.38) (18.18) (75.65) 20.66 7.34 60.82 7.62 (91.94)
Investments Change (Net)
(89.25) (143.15) (94.05) (64.43) (324.95) (324.16) (994.17) (1,050.15) (679.62) (1,075.23)
Issuance/Purchase of Shares
12.36 20.77 25.91 10.99 34.86 51.54 43.65 62.69 105.54 83.91
Other line items
Revenue per Employee
0.31 0.32 0.34 0.32 0.33 0.34 0.32 0.33 0.38 0.40

Fold the line items

In millions of $ except per-share values · columns are period end dates